Clinical outcomes of the treatment of exudative age-related macular degeneration with Pegaptanib

Clinical outcomes of the treatment of exudative age-related macular degeneration with Pegaptanib

Show other versions (1)

ABSTRACT Purpose. To evaluate the results of intravitreal use of Pegaptanib in patients with exudative age-related macular degeneration (AMD). Material end methods. Our study includes 77 patients with exudative AMD, who received 9 injections of Pegaptanib 0.3mg with 6-weeks intervals...

Full description

Bibliographic Details
Main Authors: M. Burova, J. Studnicka, N. Jiraskova, P. Rozsival, M. Kalfertova
Format: Article
Language:Russian
Published: Publishing house "Ophthalmology" 2013-02-01
Series:Офтальмохирургия
Subjects:
age-related macular degeneration
choroidal neovascularization
exudative
Pegaptanib
treatment
Online Access:http://www.eyepress.ru/article.aspx?11588

Similar Items

Similar Items